Evaluation of chronic hypoparathyroidism course according to the Database of Endocrinology Research Centre

BACKGRAUND: Currently high frequency of thyroid or parathyroid surgery is associated with significant increased incidence of hypoparathyroidism. Evaluation of the epidemiological and clinical features of chronic hypoparathyroidism is necessary to predict social-significant complications and to improve the quality of medical care.

AIMS: To estimate clinical and demographic features, different regimens and efficacy of conventional therapy in patients with chronic postsurgical and nonsurgical hypoparathyroidism.

MATERIALS AND METHODS: The cross-sectional, observational, continuous study was carried out based on Database of patients with chronic postsurgical and nonsurgical hypoparathyroidism of Endocrinology Research Centre, Moscow. 293 patients from 61 regions of the Russian Federation were included in this study. Statistical analysis was done on June 2020. The descriptive statistics are presented by medians (Ме) and the first and third quartiles (Q1; Q3) and by absolute and relative frequencies.

RESULTS: Hypoparathyroidism was most often recorded in women (85%) at the age of 43 [32; 52] years, after thyroid surgery. Less than a half of the study group had target indicators of serum calcium and phosphate levels (31% and 47%, respectively) despite ongoing treatment. A complex instrumental examination for the disease complications was performed in 58% of cases (n = 169). Among them, kidney disorders were detected in 38%, visual disturbance in 14%, brain calcification in 10%, arrhythmias in 4% and neuropsychiatric symptoms in 6%. Conventional therapy with calcium supplements and activated vitamin D analogues was noted in 75% of patients.

CONCLUSIONS: The analysis of large databases of patients with chronic hypoparathyroidism is a necessary tool for determining of optimal clinical and therapeutic approaches, as well as prognostic markers of disease complications.

1. Powers J, et al. Prevalence and incidence of hypoparathyroidism in the United States Using a large claims database. J. Bone Miner. Res. 2013;28(12):2570-2576. doi:10.1002/jbmr.2004.

2. Abate EG, Clarke BL. Review of Hypoparathyroidism. Front. Endocrinol. (Lausanne). 2016;7:172. doi:10.3389/fendo.2016.00172.

3. Iqbal K, et al. Defining the Characteristics of Chronic Hypoparathyroidism Not Adequately Controlled on Conventional Therapy: Consensus Findings of Three European Delphi Panels. Adv. Ther. 2019;36(11):3007-3016. doi:10.1007/s12325-019-01102-5.

4. Bollerslev J, et al. European Society of Endocrinology Clinical Guideline: Treatment of chronic hypoparathyroidism in adults. Eur. J. Endocrinol. 2015;173(2). doi: 10.1530/EJE-15-0628.

5. Khan AA, et al. Standards of care for hypoparathyroidism in adults: A Canadian and international consensus. Eur. J. Endocrinol. 2019;180(3):1-P22. doi:10.1530/EJE-18-0609.

6. Mitchell DM, et al. Long-term follow-up of patients with hypoparathyroidism. J. Clin. Endocrinol. Metab. 2012;97(12):4507-4514. doi:10.1210/jc.2012-1808.

7. Shoback DM, et al. Presentation of hypoparathyroidism: Etiologies and clinical features. J. Clin. Endocrinol. Metab. 2016;101(6):2300-2312. doi:10.1210/jc.2015-3909.

8. Underbjerg L, et al. Postsurgical hypoparathyroidism-Risk of fractures, Psychiatric Diseases, Cancer, Cataract, and Infections. J. Bone Miner. Res. 2014;29(S1):2504-2510. doi:10.1002/jbmr.2273.

9. Levy I, et al. The impact of hypoparathyroidism treatment on the kidney in children: Long-term retrospective follow-up study. J. Clin. Endocrinol. Metab. 2015;100(11):4106-4113. doi:10.1210/jc.2015-2257.

10. Daba KT, Weldemichael DK, Mulugeta GA. Bilateral hypocalcemic cataract after total thyroidectomy in a young woman: case report. BMC Ophthalmol. 2019;19(1):233. doi:10.1186/s12886-019-1224-9.

11. Saha S, et al. Long-term outcome of cataract surgery in patients with idiopathic hypoparathyroidism and its relationship with their calcemic status. J. Bone Miner. Metab. 2017;35(4):405-411. doi:10.1007/s00774-016-0767-6.

12. Goswami R, et al. Prevalence and progression of basal ganglia calcification and its pathogenic mechanism in patients with idiopathic hypoparathyroidism. Clin. Endocrinol. (Oxf). 2012;77(2):200-206. doi:10.1111/j.1365-2265.2012.04353.x.

13. Newman DB, et al. Reversible cardiac dysfunction associated with hypocalcemia: A systematic review and meta-analysis of individual patient data. Heart Fail. Rev. 2014;19(2):199-205. doi:10.1007/s10741-013-9371-1.

14. Kim SH, et al. Prevalence and complications of nonsurgical hypoparathyroidism in Korea: A nationwide cohort study. PLoS One. 2020;15(5):e0232842. https://doi.org/10.1371/journal.pone.0232842.

15. Underbjerg L, et al. Cardiovascular and renal complications to postsurgical hypoparathyroidism: A Danish nationwide controlled historic follow-up study. J. Bone Miner. Res. 2013;28(1 1):2277-2285. doi:10.1002/jbmr.1979.

16. Jensterle M, et al. Dihydrotachysterol intoxication treated with pamidronate: a case report. Cases J. 2010;3(1):78. doi:10.1186/1757-1626-3-78.

17. Quack I, et al. Dihydrotachysterol therapy for hypoparathyroidism: consequences of inadequate monitoring. Five cases and a review. Exp. Clin. Endocrinol. diabetes Off. journal, Ger. Soc. Endocrinol. [and] Ger. Diabetes Assoc. Germany, 2005;113(7):376-380. doi:10.1055/s-2005-865724.

18. Garda-Pascual L, et al. Serum 1,25-Dihydroxyvitamin D as a Biomarker of the Absence of Hypercalciuria in Postsurgical Hypoparathyroidism. J. Clin. Endocrinol. Metab. United States, 2017;102(1):259-266. doi:10.1210/jc.2016-2987.

19. Winer K.K, et al. Long-Term Parathyroid Hormone 1-34 Replacement Therapy in Children with Hypoparathyroidism. J. Pediatr. 2018;203):391-399.e1. doi:10.1016/j.jpeds.2018.08.010.

20. Mannstadt M, et al. Safety and Efficacy of 5 Years of Treatment With Recombinant Human Parathyroid Hormone in Adults With Hypoparathyroidism. J. Clin. Endocrinol. Metab. 2019;104(11):5136-5147. doi:10.1210/jc.2019-01010.